From €2008EUR$2,100USD£1,725GBP
€2868EUR$3,000USD£2,465GBP
- Report
- January 2022
- 56 Pages
Global
From €3585EUR$3,750USD£3,081GBP
- Report
- October 2019
- 214 Pages
Global
From €4780EUR$5,000USD£4,108GBP
- Report
- March 2022
- 312 Pages
Global
From €6692EUR$7,000USD£5,751GBP
- Report
- April 2022
- 224 Pages
Global
From €4732EUR$4,950USD£4,067GBP
- Report
- July 2020
- 118 Pages
Global
From €1616EUR$1,690USD£1,388GBP
- Report
- April 2021
- 302 Pages
Global
From €1315EUR$1,375USD£1,130GBP
€2629EUR$2,750USD£2,259GBP
- Report
- February 2023
- 287 Pages
Global
From €5258EUR$5,500USD£4,518GBP
- Report
- May 2023
- 150 Pages
Global
From €5688EUR$5,950USD£4,888GBP
- Report
- April 2022
- 290 Pages
Global
From €3991EUR$4,175USD£3,430GBP
- Report
- May 2022
- 120 Pages
India
From €4541EUR$4,750USD£3,902GBP
- Report
- March 2023
- 116 Pages
Global
From €4684EUR$4,900USD£4,026GBP
- Report
- April 2023
- 57 Pages
Asia Pacific
From €4732EUR$4,950USD£4,067GBP
- Report
- April 2023
- 134 Pages
Global
From €4541EUR$4,750USD£3,902GBP
- Report
- August 2023
- 177 Pages
From €2008EUR$2,100USD£1,725GBP
€2868EUR$3,000USD£2,465GBP
- Report
- August 2022
- 118 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- March 2023
- 116 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- December 2021
- 100 Pages
Global
From €4302EUR$4,500USD£3,697GBP
- Report
- September 2019
- 40 Pages
Saudi Arabia
From €2481EUR$2,595USD£2,132GBP
- Report
- September 2019
- 40 Pages
India
From €2481EUR$2,595USD£2,132GBP
The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence.
Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events.
Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more